WallStreetZenWallStreetZen

NASDAQ: LYEL
Lyell Immunopharma Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Lyell Immunopharma earnings were -$248.5M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest LYEL earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$44.8M, up 85.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LYEL reported annual earnings of -$274.4M, with -20% growth.

LYEL earnings history

Current Revenue
$25.0k
Current Earnings
-$248.5M
Current Profit Margin
-993,908%

LYEL Return on Equity

Current Company
-91.6%
Current Industry
-13.5%
Current Market
29%
LYEL's Return on Equity (-91.6%)... subscribe to Premium to read more.
High Return on Equity Performance

LYEL Return on Assets

Current Company
-70.5%
Current Industry
-10.3%
LYEL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LYEL announces earnings.

LYEL Return on Capital Employed

Current Company
-91.59%
Current Industry
-7%
LYEL's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LYEL vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LYEL-$238.96M-$248.48MN/A-$12.83
ENTA-$45.31M-$63.23MN/A-$2.42
UPB-$155.70M-$156.50MN/A-$2.89
FHTX-$60.12M-$64.58MN/A-$0.98
LXEO-$85.02M-$87.27MN/A-$1.02
View Top Biotech Stocks

Lyell Immunopharma Earnings Reports & History FAQ

What were Lyell Immunopharma's earnings last quarter?

On LYEL's earnings call on Aug 11, 2026, Lyell Immunopharma (NASDAQ: LYEL) reported Q2 2026 earnings per share (EPS) of -$1.92, up 33.56% year over year. Total LYEL earnings for the quarter were -$44.76 million. In the same quarter last year, Lyell Immunopharma's earnings per share (EPS) was -$2.89.

If you're new to stock investing, here's how to buy Lyell Immunopharma stock.

Is Lyell Immunopharma profitable or losing money?

As of the last Lyell Immunopharma earnings report, Lyell Immunopharma is currently losing money. Lyell Immunopharma's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$248.48 million, a 25.02% decrease year over year.

What was LYEL's earnings growth in the past year?

As of Lyell Immunopharma's earnings date in Aug 11, 2026, Lyell Immunopharma's earnings has grown year over year. LYEL earnings in the past year totalled -$248.48 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.